AWS
WST icon

Atria Wealth Solutions’s West Pharmaceutical WST Stock Holding History

Atria Wealth Solutions’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$246K Sell
1,123
-2,898
-72% -$620K 0.01% 1261
2025
Q1 		$900K Buy
4,021
+1,258
+46% +$347K 0.01% 930
2024
Q4 		$905K Sell
2,763
-205
-7% -$64.5K 0.01% 964
2024
Q3 		$891K Sell
2,968
-318
-10% -$97.4K 0.01% 951
2024
Q2 		$1.08M Sell
3,286
-309
-9% -$109K 0.01% 864
2024
Q1 		$1.42M Sell
3,595
-88
-2% -$32.6K 0.02% 754
2023
Q4 		$1.3M Sell
3,683
-29
-0.8% -$10.3K 0.02% 761
2023
Q3 		$1.39M Sell
3,712
-163
-4% -$63K 0.02% 686
2023
Q2 		$1.48M Sell
3,875
-116
-3% -$41.4K 0.02% 684
2023
Q1 		$1.38M Sell
3,991
-149
-4% -$43.5K 0.02% 686
2022
Q4 		$974K Sell
4,140
-401
-9% -$95K 0.02% 762
2022
Q3 		$1.12M Buy
4,541
+568
+14% +$173K 0.02% 682
2022
Q2 		$1.2M Sell
3,973
-2,985
-43% -$971K 0.02% 627
2022
Q1 		$2.86M Buy
+6,958
New +$2.72M 0.05% 386

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Atria Wealth Solutions's WST Position: Q2 2025 in Review

Atria Wealth Solutions reduced its West Pharmaceutical (WST) stake by 72% in Q2 2025, selling an estimated $620K and leaving 1,123 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #1261.

Atria Wealth Solutions first reported a position in WST in Q1 2022 and has held it in 14 quarters since. The position peaked at $2.86M in Q1 2022. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Atria Wealth Solutions held 1,123 shares of West Pharmaceutical worth $246K as of Q2 2025.
  • Atria Wealth Solutions sold 2,898 West Pharmaceutical shares in Q2 2025, an estimated $620K.
  • West Pharmaceutical made up 0.01% of Atria Wealth Solutions's portfolio in Q2 2025, its #1261 holding.
  • Atria Wealth Solutions first reported a position in West Pharmaceutical in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's West Pharmaceutical position peaked at $2.86M in Q1 2022.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.